心因性瘙痒诊断与管理专家共识（2026版）

doi:10.35541/cjd.20260259

Abstract

Abstract: 【Abstract】 Psychogenic pruritus is a pruritic disorder in which psychological,mental,and psychosomatic factors play a critical role in the onset, aggravation, or persistence of the condition, substantially affecting the quality of life of patients and their families. Psychogenic pruritus is not rare in clinical practice, and misdiagnosis and mistreatment are relatively common. To standardize the management of psychogenic pruritus, the Psychodermatology Group of the Chinese Society of Psychosomatic Medicine, the China Dermatologist Association, and the Chinese Association of Rehabilitation Dermatology convened a panel of experts in relevant fields to develop the “Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）”, based on Chinese and international literature, experts' clinical experience, and the current status of diagnosis and treatment of psychogenic pruritus in China.

Key words: Pruritus, Psychogenic pruritus, Diagnosis, Treatment, Expert consensus

Psychodermatology Group, Chinese Society of Psychosomatic Medicine, China Dermatologist Association, Chinese Association of Rehabilitation Dermatology. Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）[J]. Chinese Journal of Dermatology, 2026, 59(11): 1027-1035.doi:10.35541/cjd.20260259

References ［69］

［1］	Ständer S, Schmelz M, Lerner E, et al. A multidisciplinary Delphi consensus on the modern definition of pruritus: sensation and disease［J］. J Eur Acad Dermatol Venereol, 2026,40（1）:59⁃66. DOI: 10.1111/jdv.20851.
［2］	Ständer S, Weisshaar E, Mettang T, et al. Clinical classification of itch: a position paper of the International Forum for the Study of Itch［J］. Acta Derm Venereol, 2007,87（4）:291⁃294. DOI: 10.2340/00015555⁃0305.
［3］	中国康复医学会皮肤病康复专业委员会, 中国中西医结合学会皮肤性病专业委员会老年皮肤病学组. 老年皮肤瘙痒症诊疗与康复专家共识（2025版）［J］. 中华皮肤科杂志, 2025,58（1）:1⁃8. DOI: 10.35541/cjd.20240407.
［4］	Misery L, Alexandre S, Dutray S, et al. Functional itch disorder or psychogenic pruritus: suggested diagnosis criteria from the French Psychodermatology Group［J］. Acta Derm Venereol, 2007, 87（4）: 341⁃344. DOI: 10.2340/00015555⁃0266.
［5］	Weisshaar E, Müller S, Szepietowski JC, et al. European S2k guideline on chronic pruritus［J］. Acta Derm Venereol, 2025,105:adv44220. DOI: 10.2340/actadv.v105.44220.
［6］	Mazeh D, Melamed Y, Cholostoy A, et al. Itching in the psychiatric ward［J］. Acta Derm Venereol, 2008,88（2）:128⁃131. DOI: 10.2340/00015555⁃0406.
［7］	Kretzmer GE, Gelkopf M, Kretzmer G, et al. Idiopathic pruritus in psychiatric inpatients: an explorative study［J］. Gen Hosp Psychiatry, 2008,30（4）:344⁃348. DOI: 10.1016/j.genhosppsych. 2008.03.006.
［8］	Kazmi A, Leslie T. Psychogenic pruritus［M］//Bewley A, Lepping P, Taylor R. Psychodermatology in clinical practice. Cham: Springer, 2021:303⁃315. DOI: 10.1007/978⁃3⁃030⁃54307⁃5_23.
［9］	中国医师协会皮肤科医师分会. 慢性瘙痒管理指南（2024版）［J］. 中华皮肤科杂志, 2024,57（5）:387⁃399. DOI: 10. 35541/cjd.20230746.
［10］	谢志强, 傅君舟, 陈敢, 等. 改良川岛瘙痒严重度评价方法与视觉模拟评分法的相关性［J］. 中国医学科学院学报, 2018,40（4）:539⁃542. DOI: 10.3881/j.issn.1000⁃503X.10320.
［11］	Zeidler C, Pereira MP, Augustin M, et al. Investigator's global assessment of chronic prurigo: a new instrument for use in clinical trials［J］. Acta Derm Venereol, 2021,101（2）:adv00401. DOI: 10.2340/00015555⁃3701.
［12］	Bewley A, Taylor RE, Reichenberg JS, et al. 实用精神皮肤病学［M］. 谢志强, 岳伟华, 译. 北京: 北京大学医学出版社, 2017: 281⁃296.
［13］	Tong X, An D, McGonigal A, et al. Validation of the Generalized Anxiety Disorder⁃7 （GAD⁃7） among Chinese people with epilepsy［J］. Epilepsy Res, 2016,120:31⁃36. DOI: 10.1016/j.eplepsyres.2015.11.019.
［14］	Leung DY, Lam TH, Chan SS. Three versions of Perceived Stress Scale: validation in a sample of Chinese cardiac patients who smoke［J］. BMC Public Health, 2010,10:513. DOI: 10.1186/1471⁃2458⁃10⁃513.
［15］	Leising D, Grande T, Faber R. The Toronto Alexithymia Scale （TAS⁃20）: a measure of general psychological distress［J］. J Res Pers, 2009, 43（4）: 707⁃710. DOI: 10.1016/j.jrp.2009.03.009.
［16］	Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research［J］. Sleep Med, 2001,2（4）:297⁃307. DOI: 10.1016/s1389⁃9457（00）00065⁃4.
［17］	Verhoeven EW, de Klerk S, Kraaimaat FW, et al. Biopsychosocial mechanisms of chronic itch in patients with skin diseases: a review［J］. Acta Derm Venereol, 2008,88（3）:211⁃218. DOI: 10.2340/00015555⁃0452.
［18］	Ferreira BR, Katamanin OM, Jafferany M, et al. Psychodermatology of chronic pruritus: an overview of the link between itch and distress［J］. Dermatol Ther （Heidelb）, 2024,14（7）:1799⁃1809. DOI: 10.1007/s13555⁃024⁃01214⁃z.
［19］	Zhang H, Wang M, Zhao X, et al. Role of stress in skin diseases: a neuroendocrine⁃immune interaction view［J］. Brain Behav Immun, 2024, 116: 286⁃302. DOI: 10.1016/j.bbi.2023.12.005.
［20］	Herman JP, Figueiredo H, Mueller NK, et al. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo⁃pituitary⁃adrenocortical responsiveness［J］. Front Neuroendocrinol, 2003,24（3）:151⁃180. DOI: 10. 1016/j.yfrne.2003.07.001.
［21］	Kim JE, Cho BK, Cho DH, et al. Expression of hypothalamic⁃pituitary⁃adrenal axis in common skin diseases: evidence of its association with stress⁃related disease activity［J］. Acta Derm Venereol, 2013,93（4）:387⁃393. DOI: 10.2340/00015555⁃1557.
［22］	Golpanian RS, Kim HS, Yosipovitch G. Effects of stress on itch［J］. Clin Ther, 2020,42（5）:745⁃756. DOI: 10.1016/j.clinthera. 2020.01.025.
［23］	Arck P, Paus R. From the brain⁃skin connection: the neuroendocrine⁃immune misalliance of stress and itch［J］. Neuroimmunomodulation, 2006,13（5⁃6）:347⁃356. DOI: 10. 1159/000104863.
［24］	Aberg KM, Radek KA, Choi EH, et al. Psychological stress downregulates epidermal antimicrobial peptide expression and increases severity of cutaneous infections in mice［J］. J Clin Invest, 2007,117（11）:3339⁃3349. DOI: 10.1172/JCI31726.
［25］	Gonzalez T, Bilik SM, Burke OM, et al. Host⁃microbiome interactions in chronic itch［J］. J Clin Med, 2025, 14（16）: 5633. DOI: 10.3390/jcm14165633.
［26］	Coccurello R. The skin microbiome and affective symptoms: neuroimmune, neuroendocrine, and sensory pathways linking inflammatory dermatoses to mood and anxiety burden［J］. Front Neuroendocrinol, 2026,81:101251. DOI: 10.1016/j.yfrne.2026. 101251.
［27］	Elenkov IJ. Glucocorticoids and the Th1/Th2 balance［J］. Ann N Y Acad Sci, 2004, 1024: 138⁃146. DOI: 10.1196/annals.1321. 010.
［28］	Khalil NB, Coscarella G, Dhabhar FS, et al. A narrative review on stress and itch: what we know and what we would like to know［J］. J Clin Med, 2024, 13（22）: 6854. DOI: 10.3390/jcm13226854.
［29］	Heijnen CJ. Receptor regulation in neuroendocrine⁃immune communication: current knowledge and future perspectives［J］. Brain Behav Immun, 2007,21（1）:1⁃8. DOI: 10.1016/j.bbi. 2006.08.008.
［30］	Ulrich⁃Lai YM, Herman JP. Neural regulation of endocrine and autonomic stress responses［J］. Nat Rev Neurosci, 2009,10（6）:397⁃409. DOI: 10.1038/nrn2647.
［31］	Nakagawa Y, Yamada S. Alterations in brain neural network and stress system in atopic dermatitis: novel therapeutic interventions［J］. J Pharmacol Exp Ther, 2023,385（2）:78⁃87. DOI: 10.1124/jpet.122.001482.
［32］	Pavlenko D, Akiyama T. Why does stress aggravate itch? A possible role of the amygdala［J］. Exp Dermatol, 2019,28（12）:1439⁃1441. DOI: 10.1111/exd.13941.
［33］	McConnell I, Davis JM, Mishra SK. Comorbid depression in atopic dermatitis⁃the itch⁃to⁃brain circuitry theory［J］. JAMA Psychiatry, 2026,83（5）:435⁃436. DOI: 10.1001/jamapsychiatry. 2026.0029.
［34］	Tian J, Cao Y, Li Y, et al. A sympathetic⁃eosinophil axis orchestrates psychological stress to exacerbate skin inflammation［J］. Science, 2026,391（6791）:1269⁃1277. DOI: 10.1126/science. adv5974.
［35］	Xie X, Jiang W, Lun L, et al. Hyperactivation of sympathetic nerves fuels basophil infiltration in atopic dermatitis［J］. Immunity, 2026,59（3）:598⁃617. DOI: 10.1016/j.immuni. 2026. 01.010.
［36］	Scott⁃Solomon E, Brielle S, Mann AO, et al. Stress⁃induced sympathetic hyperactivation drives hair follicle necrosis to trigger autoimmunity［J］. Cell, 2026,189（1）:252⁃271. DOI: 10. 1016/j.cell.2025.10.042.
［37］	Huang L, Kang P, Chen J, et al. Sympathetic nerve aggravates autoimmune skin disease via NE⁃adrenergic receptor axis: neuroimmune cross⁃talk insights from vitiligo［J］. Sci Adv, 2026,12（10）:eaea7017. DOI: 10.1126/sciadv.aea7017.
［38］	Qu L, Fu K, Yang J, et al. CXCR3 chemokine receptor signaling mediates itch in experimental allergic contact dermatitis［J］. Pain, 2015,156（9）:1737⁃1746. DOI: 10.1097/j.pain.00000000 00000208.
［39］	Yu S, Xu Y, Li Y, et al. Sympathetic nerve dysfunction exacerbates skin inflammation in atopic dermatitis［J］. J Allergy Clin Immunol, 2026,157（3）:677⁃692. DOI: 10.1016/j.jaci.2025. 12.994.
［40］	Kim HS, Yosipovitch G. An aberrant parasympathetic response: a new perspective linking chronic stress and itch［J］. Exp Dermatol, 2013,22（4）:239⁃244. DOI: 10.1111/exd.12070.
［41］	Welcome MO. Cellular mechanisms and molecular signaling pathways in stress⁃induced anxiety, depression, and blood⁃brain barrier inflammation and leakage［J］. Inflammopharmacology, 2020,28（3）:643⁃665. DOI: 10.1007/s10787⁃020⁃00712⁃8.
［42］	Zhang Z, Li H, Yang J, et al. Interleukin⁃17 plays a crucial role in atopic dermatitis⁃associated blood⁃brain barrier disruption and cognitive impairment［J］. Brain Behav Immun, 2026,136: 106564. DOI: 10.1016/j.bbi.2026.106564.
［43］	Montague⁃Cardoso K, Malcangio M. Changes in blood⁃spinal cord barrier permeability and neuroimmune interactions in the underlying mechanisms of chronic pain［J］. Pain Rep, 2021,6（1）:e879. DOI: 10.1097/PR9.0000000000000879.
［44］	Hermans D, Houben E, Baeten P, et al. Oncostatin M triggers brain inflammation by compromising blood⁃brain barrier integrity［J］. Acta Neuropathol, 2022,144（2）:259⁃281. DOI: 10.1007/s00401⁃022⁃02445⁃0.
［45］	Sarapultsev A, Gusev E, Komelkova M, et al. JAK⁃STAT signaling in inflammation and stress⁃related diseases: implications for therapeutic interventions［J］. Mol Biomed, 2023,4（1）:40. DOI: 10.1186/s43556⁃023⁃00151⁃1.
［46］	Lee J, Wheeler MA. Immune⁃brain plasticity underpins stress and affective behaviors［J］. Neuron, 2026,114（1）:9⁃32. DOI: 10.1016/j.neuron.2025.11.020.
［47］	Biazus Soares G, Mahmoud O, Yosipovitch G, et al. The mind⁃skin connection: a narrative review exploring the link between inflammatory skin diseases and psychological stress［J］. J Eur Acad Dermatol Venereol, 2024,38（5）:821⁃834. DOI: 10.1111/jdv.19813.
［48］	Zeidler C, Kupfer J, Dalgard FJ, et al. Dermatological patients with itch report more stress, stigmatization experience, anxiety and depression compared to patients without itch: results from a European multi⁃centre study［J］. J Eur Acad Dermatol Venereol, 2024,38（8）:1649⁃1661. DOI: 10.1111/jdv.19913.
［49］	Ishiuji Y. Addiction and the itch⁃scratch cycle: what do they have in common?［J］. Exp Dermatol, 2019,28（12）:1448⁃1454. DOI: 10.1111/exd.14029.
［50］	Hania A, Jamil S, Jamil S. How psychological distress translates into psychogenic pruritus: alexithymia, body awareness, and coping in a Pakistani collectivistic sample［J］. J Psychosom Res, 2026,205:112607. DOI: 10.1016/j.jpsychores.2026.112607.
［51］	Ferreira BR, Misery L. Alexithymia and dissociation in psychogenic pruritus: clinical relevance and therapeutic implications［J］. J Eur Acad Dermatol Venereol, 2024,38（9）: e813⁃e815. DOI: 10.1111/jdv.19918.
［52］	Faria M, Ganz A, Galkin F, et al. Psychogenic aging: a novel prospect to integrate psychobiological hallmarks of aging［J］. Transl Psychiatry, 2024,14（1）:226. DOI: 10.1038/s41398⁃024⁃02919⁃7.
［53］	Orliaguet M, Brenaut E, Ficheux AS, et al. Psychogenic and neurogenic components in patients with psychogenic or neuropathic pruritus: PRURINEURO: a non⁃interventional single⁃centre prospective assay［J］. Skin Health Dis, 2023,3（6）:e267. DOI: 10.1002/ski2.267.
［54］	Patel A, Jafferany M. Multidisciplinary and holistic models of care for patients with dermatologic disease and psychosocial comorbidity: a systematic review［J］. JAMA Dermatol, 2020,156（6）:686⁃694. DOI: 10.1001/jamadermatol.2020.0394.
［55］	Buteau A, Reichenberg J. Psychogenic pruritus and its management［J］. Dermatol Clin, 2018,36（3）:309⁃314. DOI: 10.1016/j.det.2018.02.015.
［56］	Schuch FB, Vancampfort D, Richards J, et al. Exercise as a treatment for depression: a meta⁃analysis adjusting for publication bias［J］. J Psychiatr Res, 2016,77:42⁃51. DOI: 10.1016/j.jpsychires.2016.02.023.
［57］	Stubbs B, Vancampfort D, Rosenbaum S, et al. An examination of the anxiolytic effects of exercise for people with anxiety and stress⁃related disorders: a meta⁃analysis［J］. Psychiatry Res, 2017,249:102⁃108. DOI: 10.1016/j.psychres.2016.12.020.
［58］	Ju Y, Pei H, Kang N, et al. Prevalence and potential risk factors of chronic pruritus among community middle⁃aged and older population in Beijing, China［J］. J Eur Acad Dermatol Venereol, 2022,36（7）:1074⁃1079. DOI: 10.1111/jdv.18041.
［59］	Ghani H, Ghofrani S, Modanlo N, et al. Novel and existing therapeutic interventions in psychogenic pruritus［J］. Clin Exp Dermatol, 2026,51（6）:951⁃957. DOI: 10.1093/ced/llag005.
［60］	Demirbas A, Diremsizoglu E, Esen M, et al. Comparative effectiveness and safety of upadacitinib, abrocitinib and dupilumab in treatment⁃resistant prurigo nodularis［J］. Clin Exp Dermatol, 2026,51（4）:587⁃595. DOI: 10.1093/ced/llaf518.
［61］	Vahabi SM, Heidari S, Pourgholi E, et al. Janus kinase inhibitors for the treatment of prurigo nodularis: a systematic review of 211 patients［J］. J Dermatol, 2026,53（4）:556⁃577. DOI: 10.1111/1346⁃8138.70150.
［62］	Shafiyev J, Gahramanov I. Evaluating duloxetine for pruritus and psychiatric comorbidities in lichen simplex chronicus［J］. Arch Dermatol Res, 2025,317（1）:249. DOI: 10.1007/s00403⁃024⁃03775⁃7.
［63］	Kwatra SG, Bordeaux ZA, Parthasarathy V, et al. Efficacy and safety of abrocitinib in prurigo nodularis and chronic pruritus of unknown origin: a nonrandomized controlled trial［J］. JAMA Dermatol, 2024,160（7）:717⁃724. DOI: 10.1001/jamadermatol. 2024.1464.
［64］	Ghani H, Ghofrani S, Jafferany M. Therapeutic challenges and novel treatment options in psychogenic pruritus［J］. Arch Dermatol Res, 2024,317（1）:121. DOI: 10.1007/s00403⁃024⁃03644⁃3.
［65］	Ho CY, Wu HL, Dai YX, et al. Association of Janus kinase inhibitors with reduced depression in alopecia areata［J］. J Eur Acad Dermatol Venereol, 2026,40（8）:1382⁃1391. DOI: 10. 1111/jdv.70184.
［66］	Nettis E, Cristallo M, Fiorella CS, et al. Upadacitinib is efficacious in reducing the alexithymic trait in adult patients with moderate⁃to⁃severe atopic dermatitis: a prospective multicenter real⁃life study［J］. Ital J Dermatol Venerol, 2025,160（5）:398⁃405. DOI: 10.23736/S2784⁃8671.25.08228⁃3.
［67］	Frankel D, Ma E, Gage D, et al. Cross⁃sectional analysis of mental health comorbidities in patients with prurigo nodularis［J］. J Am Acad Dermatol, 2025, 93（1）: 270⁃272. DOI: 10.1016/j.jaad.2025.03.015.
［68］	Ständer S, Elmariah SB, Kwatra SG, et al. Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies［J］. J Eur Acad Dermatol Venereol, 2026,40（5）:867⁃875. DOI: 10.1111/jdv.70250.
［69］	Gruzmark FS, Yosipovitch G, Lev⁃Tov HA. Resolution of lichen simplex chronicus with nemolizumab: a case report［J］. J Drugs Dermatol, 2025,24（12）:1252⁃1253. DOI: 10.36849/JDD.9273.

[1]	China Dermatologist Association, Chinese Society of Dermatology, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on the long-term management of plaque psoriasis with biologic agents （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(9): 827-843.
[2]	Liang Yunsheng. Chronic hand eczema: current status and progress in clinical assessment [J]. Chinese Journal of Dermatology, 2026, 59(9): 850-855.
[3]	Tang Zhen¹, Liu Yuhang¹, Yang Ling², Hu Lingxue¹, He Zhijie¹, Cao Kai¹, Ding Shu¹. Value and features of reflectance confocal microscopy in the diagnosis and differential diagnosis of cutaneous lupus erythematosus [J]. Chinese Journal of Dermatology, 2026, 59(9): 873-880.
[4]	Chinese Society of Dermatology, Chinese Society of Allergy, China Leprosy Association. Chinese guideline for the diagnosis and treatment of drug eruptions （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(9): 811-826.
[5]	Expert Group on the “Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma （ edition）”. Chinese expert consensus on sirolimus in the treatment of Kaposiform hemangioendothelioma （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 728-737.
[6]	Chinese Society of Dermatology, China Dermatologist Association. Chinese guideline for the diagnosis and treatment of cutaneous squamous cell carcinoma （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 703-716.
[7]	Writing Committee Expert Group on “Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （ edition）”. Diagnosis and treatment of pustular psoriasis: a Chinese expert consensus statement （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(8): 717-727.
[8]	Wang Linlin, Cao Lijuan, Chen Liuqing, Li Dongsheng, Hu Yanyan. Efficacy and safety of hemoporfin-mediated photodynamic therapy for port-wine stains on the extremities: a retrospective analysis [J]. Chinese Journal of Dermatology, 2026, 59(7): 637-644.
[9]	Liu Yifei, Kim Hyunok¹, Liu Pengyue³, Zhang Ximeng³, Wu Yan³. Fractional CO? laser combined with topical botulinum toxin type A for the treatment of enlarged facial pores: a split-face self-controlled clinical trial [J]. Chinese Journal of Dermatology, 2026, 59(7): 645-653.
[10]	He Qing, Zhang Tao, Wang Xiuli, Gao Xinghua, Chen Hongduo, Liu Min, Qi Ruiqun. Biomarkers associated with malignant progression of actinic keratosis [J]. Chinese Journal of Dermatology, 2026, 59(7): 687-690.
[11]	Tian Jing, Song Zhiqiang. Application of tape stripping to the detection of biomarkers in atopic dermatitis [J]. Chinese Journal of Dermatology, 2026, 59(6): 578-581.
[12]	Du Xinran, Wang Xinhe, Li Siyu, Chen Moan, Yuan Shaojie, Yan Ran, Cheng Linyan, Guo Wanjun, Wang Yi, Li Fulun. Development and evaluation of a diagnostic scale for atopic dermatitis with the syndrome of wind dryness due to blood deficiency [J]. Chinese Journal of Dermatology, 2026, 59(6): 540-546.
[13]	Li Wei¹, Yao Xu². Research on atopic dermatitis in China: current status and future perspectives [J]. Chinese Journal of Dermatology, 2026, 59(6): 505-511.
[14]	Li Fang, Lin Ying. Diagnosis and treatment of atopic dermatitis of the head and neck [J]. Chinese Journal of Dermatology, 2026, 59(6): 586-590.
[15]	Chinese Society of Dermatology, China Dermatologist Association, Dermatology Branch of China International Exchange and Promotive Association for Medical and Health Care, Dermatology Branch of China Alliance for Rare Diseases. Expert consensus on fecal microbiota transplantation in the treatment of psoriasis （2026 edition） [J]. Chinese Journal of Dermatology, 2026, 59(5): 427-435.

Expert consensus on the diagnosis and management of psychogenic pruritus （2026 edition）

PDF

Knowledge

Abstract

Cite this article

share this article

References ［69］

Related Articles 15

Metrics

Comments

Recommended 2